Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy

Clinical Therapeutics

Volumn 32, Issue 3, 2010, Pages 527-531

  Suzuki, Takaaki ^a   Takeuchi, Masahiro ^b   Saeki, Hiromi ^a   Yamazaki, Shingo ^a   Koga, Hitomi ^a   Abe, Daijiro ^b   Nishimura, Miki ^b   Nakaseko, Chiaki ^b   Nakasa, Hiromitsu ^a   Nakamura, Hiroyoshi ^a   Ariyoshi, Noritaka ^a   Kitada, Mitsukazu ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute; Hypercytokinemia; Lymphoma; Tumor lysis syndrome

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BLEOMYCIN; CREATININE; DACARBAZINE; DIAZEPAM; DOXORUBICIN; HYDROCORTISONE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MIDAZOLAM; NITROGEN; ONDANSETRON; PHENYTOIN; UREA; URIC ACID; VINBLASTINE;

ACUTE DISEASE; ADULT; ANAPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BOLUS INJECTION; CASE REPORT; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; CONVULSION; CREATININE BLOOD LEVEL; CYTOKINE STORM; DRUG FEVER; DRUG INFUSION; DRUG WITHDRAWAL; HEMODIAFILTRATION; HODGKIN DISEASE; HUMAN; JAPANESE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NAUSEA; PROTEIN BLOOD LEVEL; SEDATION; SHIVERING; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TUMOR LYSIS SYNDROME; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FEVER; HODGKIN DISEASE; HUMANS; INTERLEUKIN-6; MALE; SEIZURES, FEBRILE; TUMOR LYSIS SYNDROME; UNCONSCIOUSNESS; VINBLASTINE;

EID: 77951886900     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.03.010     Document Type: Article

References (17)

1. Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review [published correction appears in J Clin Oncol. 2010;28:708]. J Clin Oncol. 2008, 26:2767-2778.
2. Mahajan A, Nirmal S, English MW, et al. Acute tumor lysis syndrome in Hodgkin disease. Med Pediatr Oncol. 2002, 39:69-70.
3. Karagiannis A, Tsorlalis I, Kakafika A, et al. Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma. Ann Hematol. 2005, 84:343-346.
4. Castro MP, VanAuken J, Spencer-Cisek P, et al. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: A case report and review of the literature. Cancer. 1999, 85:1055-1059.
5. Nakamura M, Oda S, Sadahiro T, et al. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF). Transfus Apher Sci. 2009, 40:4147.
6. Annane D, Bellissant E, Cavaillon JM Septic shock. Lancet. 2005, 365:63-78.
7. Lenz A, Franklin GA, Cheadle WG Systemic inflammation after trauma. Injury. 2007, 38:1336-1345.
8. Jücker M, Abts H, Li W, et al. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood. 1991, 77:2413-2418.
9. Klein S, Jücker M, Diehl V, Tesch H Production of multiple cytokines by Hodgkin's disease derived cell lines. Hematol Oncol. 1992, 10:319-329.
10. Hsu SM, Xie SS, Hsu PL, Waldron JA Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Am J Pathol. 1992, 141:129-138.
11. Diehl V, Stein H, Hummel M, et al. Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapsed disease. Hematology Am Soc Hematol Educ Program 2003, 225-247.
12. Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial. J Clin Oncol. 2003, 21:607-614.
13. Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 1975, 36:252-259.
14. Meyer RM, Gospodarowicz MK, Connors JM, et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limitedstage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005, 23:4634-4642. National Cancer Institute of Canada Clinical Trials Group, Eastern Cooperative Oncology GroupEastern Cooperative Oncology Group.
15. Heikkilä K, Ebrahim S, Lawlor DA Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer. 2008, 44:937-945.
16. Seymour JF, Talpaz M, Hagemeister FB, et al. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. Am J Med. 1997, 102:21-28.
17. Cattaruzza L, Gloghini A, Olivo K, et al. Functional coexpression of interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. Int J Cancer. 2009, 125:1092-1101.